Babesiosis: Clinical Trials

5 trials for Babesiosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 unknown, 1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Babesiosis: new trials by email Literature Review of Babesiosis trials Research Report on Babesiosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Human Babesiosis in Metropolitan France
Human Babesiosis
RecruitingUniversity Hospital, Strasbourg, France1002025-11-042026-01-16
FINtick - a Prospective Multicenter Study on Tick-borne Infections in Finland
Tick Borne Encephalitis (TBE), Lyme Borreliosis
RecruitingTurku University Hospital8502025-04-232026-10-27
Surveillance of Emerging Pathogens to Ensure Blood Supply Safety
Babesia NAT - Babesioses, Human
WithdrawnCanadian Blood Services2024-10-022025-08-14
Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis
Tafenoquine, Placebo - Babesiosis
Phase 2Recruiting60 Degrees Pharmaceuticals LLC332024-06-172025-11-21
Description of Case of Infection With a New Species of Babesia and Its Molecular Diagnosis
Babesiosis, Human
UnknownUniversity Hospital, Strasbourg, France12021-07-102021-07-23

Narrower conditions

Anaplasmosis (1)  ·  Encephalitis, Tick-Borne (1)  ·  Lyme Disease (1)  ·  Rickettsia Infections (1)  ·  Tick-Borne Diseases (1)  ·  Zoonoses (1)

Broader conditions

Animal Diseases (5)  ·  Infections (5)  ·  Parasitic Diseases (5)  ·  Parasitic Diseases, Animal (5)  ·  Protozoan Infections (5)  ·  Protozoan Infections, Animal (5)  ·  Vector Borne Diseases (5)  ·  Tick-Borne Diseases (4)  ·  Anaplasmataceae Infections (1)  ·  Arbovirus Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Borrelia Infections (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)

Interventions

tafenoquine (1)

Sponsors

University Hospital, Strasbourg, France (2)  ·  60 Degrees Pharmaceuticals LLC (1)  ·  Canadian Blood Services (1)  ·  Turku University Hospital (1)

Countries

France (2)  ·  Finland (1)  ·  United States (1)

Top investigators

Carmen L Charlton, PhD (1)  ·  Mindy Goldman, MD (1)  ·  Steven Drews, PhD (1)